LRRC4 and glioblastoma: Altogether, we conclude that LRRC4 may act in GBM via DEPTOR, causing MTOR pathway activation, which subsequently results in autophagy inhibition, and consequently promotes TMZ chemosensitivity in GBM patients (Fig. 8f).